Raising Your First $1Million
Funding is often the most challenging part of any startup. It can be particularly difficult to find early funds for life science companies. Come enjoy an evening with BioArbor where we will discuss “Raising Your First Million Dollars”. We will have a panel representing 3 diverse perspectives to share do’s and don’ts of this early stage of funding. Learn how decisions early on can affect your later success in fund raising and your company. Also, find out about key sources of early funding to help you be successful – angels, seed stage funds, venture, and crowd funding.
Charlie Moret: Charlie is president and CEO of Invest Michigan, the Fund Manager for the $10.5 million Michigan Pre-Seed Fund 2.0. Charlie has 35 years of diversified experience including investments, banking, business development and technology. Prior to Invest Michigan, Charlie was in a leadership role with TechTown-Detroit directing their tech-based entrepreneurial advisory services. Prior to TechTown and over a 13 year period at Connecticut Innovations, he founded and directed Connecticut’s $20 million Pre-Seed Fund, CTech, an incubator in partnership with Yale University, University of Connecticut and University of Bridgeport, TechStart, a technology venture accelerator and helped start-up the Connecticut Clean Energy Fund. Charlie brings extensive experience in pre-seed investment and management and working with universities to commercialize technologies. He has invested in over 75 early stage technology companies and currently sits on the board of seven start-ups. Prior to his work in the technology entrepreneurial sector, Charlie held a variety of senior management banking positions in international finance, asset based finance, SBA lending and credit administration.
Christine Gibbons: Chris Gibbons is President/CEO of HistoSonics, Inc., a medical device company developing a non-invasive, image-guided tissue ablation technology called histotripsy. She has over thirty years of financial management, fundraising and operating experience and for the past twenty years she has been deeply involved with early-stage technology-driven companies, both as an investor and part of a management team. Together with other founders, she has raised over $75 million in start-up capital and launched fourteen new ventures. Prior to co-founding HistoSonics, she served as Executive in Residence (EIR) with Venture Investors, LLC. Prior to her EIR role, Chris served as the CFO of Sensicore, was the VP of Finance at Ardesta, and also served as Partner and CFO of Seaflower Ventures, a venture capital firm focused on early-stage biomedical opportunities. Prior to Seaflower, Chris was CFO of MBI International, a biotechnology research institute. Chris serves as an Advisor to Apjohn Ventures Fund LP, is a member of UM’s Venture Center Council and is an advisory board member of Michigan State University’s Center for Venture Capital, Private Equity and Entrepreneurial Finance. She served as a member of the Technical Oversight Committee for the Coulter Program at the University of Michigan (UM) from 2008 – 2016 and has been a guest lecturer at Michigan State University’s Business School and Wayne State University’s Entrepreneur Network. Chris holds an MBA from Wayne State University and a BA from Michigan State University
Richard Hoeg: Richard is Founder of Hoeg Law and specializes in corporate governance, finance, and transaction law. An avid video gamer and general technologist, Rick expanded his practice in 2010 to include information technology, software licensing, and related contractual and intellectual property law issues, with a particular focus on Software-as-a-Service and custom software development. Together with his pharmaceutical and medical device clients, Rick's clients represent just some of the cutting edge technological advancement happening in Ann Arbor and the Midwest. After passage of the Jobs Act in 2012, Rick has followed and advised his clients on the SEC's slow, but continuing, push to democratize the corporate financing process through "crowdfunding" and related regulations.
BioArbor hosts educational networking events for the life sciences industry in the greater Ann Arbor area. BioArbor's focus is on technology commercialization, financing strategies, business development, regulatory affairs, and marketing. Each monthly meeting features a networking session and an invited speaker, followed by a Q&A period. Invited speakers share experience on topics such as drug discovery and development, medical devices, diagnostics, and tools. BioArbor events are open to the public and are especially suited for those interested in starting or growing life science businesses.